35 results on '"Massimo C."'
Search Results
2. External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019
- Author
-
Hassan, S, Ramspek, C, Ferrari, B, van Diepen, M, Rossio, R, Knevel, R, la Mura, V, Artoni, A, Martinelli, I, Bandera, A, Nobili, A, Gori, A, Blasi, F, Canetta, C, Montano, N, Rosendaal, F, Peyvandi, F, Bosari, S, Scudeller, L, Fusetti, G, Rusconi, L, Dell'Orto, S, Prati, D, Valenti, L, Giovannelli, S, Manunta, M, Lamorte, G, Ferarri, F, Muscatello, A, Mangioni, D, Alagna, L, Bozzi, G, Lombardi, A, Ungaro, R, Ancona, G, Zuglian, G, Bolis, M, Iannotti, N, Ludovisi, S, Comelli, A, Renisi, G, Biscarini, S, Castelli, V, Palomba, E, Fava, M, Fortina, V, Peri, C, Saltini, P, Viero, G, Itri, T, Ferroni, V, Pastore, V, Massafra, R, Liparoti, A, Muheberimana, T, Giommi, A, Bianco, R, De Azevedo, R, Chitani, G, Gualtierotti, R, Boasi, N, Pagliaro, E, Massimo, C, De Caro, M, Giachi, A, Vigone, B, Bellocchi, C, Carandina, A, Fiorelli, E, Melli, V, Tobaldini, E, Aliberti, S, Spotti, M, Terranova, L, Misuraca, S, D'Adda, A, Fiore, S, Di Pasquale, M, Mantero, M, Contarini, M, Ori, M, Morlacchi, L, Rossetti, V, Gramegna, A, Pappalettera, M, Cavallini, M, Buscemi, A, Vicenzi, M, Rota, I, Costantino, G, Solbiati, M, Furlan, L, Mancarella, M, Colombo, G, Fanin, A, Passarella, M, Monzani, V, Rovellini, A, Barbetta, L, Billi, F, Folli, C, Accordino, S, Maira, D, Hu, C, Motta, I, Scar-Amellini, N, Fracanzani, A, Lombardi, R, Cespiati, A, Cesari, M, Lucchi, T, Proietti, M, Calcaterra, L, Mandelli, C, Coppola, C, Cerizza, A, Maria Pesenti, A, Grasselli, G, Galazzi, A, Tet-Tamanti, M, Monti, I, Galbussera, A, Crisafulli, E, Girelli, D, Maroccia, A, Gabbiani, D, Busti, F, Vianello, A, Biondan, M, Sartori, F, Faverio, P, Pesci, A, Zucchetti, S, Bonfanti, P, Rossi, M, Beretta, I, Spolti, A, Harari, S, Elia, D, Cassandro, R, Caminati, A, Cipollone, F, Guagnano, M, D'Ardes, D, Rossi, I, Vezzani, F, Spanevello, A, Cherubino, F, Visca, D, Contoli, M, Papi, A, Morandi, L, Battistini, N, Luigi Moreo, G, Iannuzzi, P, Fumagalli, D, Leone, S, Oud, J, Baysan, M, Wigb, J, van Heurn, L, ter Haar, S, Toppenberg, A, Heerdink, L, van IJlzinga Veenstra, A, Eikenboom, A, Wubbolts, J, Uzorka, J, Lijferink, W, Meier, R, de Jonge, I, Arbous, S, de Boer, M, van der Bom, J, Dekkers, O, Hassan S., Ramspek C. L., Ferrari B., van Diepen M., Rossio R., Knevel R., la Mura V., Artoni A., Martinelli I., Bandera A., Nobili A., Gori A., Blasi F., Canetta C., Montano N., Rosendaal F. R., Peyvandi F., Bosari S., Scudeller L., Fusetti G., Rusconi L., Dell'Orto S., Prati D., Valenti L., Giovannelli S., Manunta M., Lamorte G., Ferarri F., Muscatello A., Mangioni D., Alagna L., Bozzi G., Lombardi A., Ungaro R., Ancona G., Zuglian G., Bolis M., Iannotti N., Ludovisi S., Comelli A., Renisi G., Biscarini S., Castelli V., Palomba E., Fava M., Fortina V., Peri C. A., Saltini P., Viero G., Itri T., Ferroni V., Pastore V., Massafra R., Liparoti A., Muheberimana T., Giommi A., Bianco R., De Azevedo R. M., Chitani G. E., Gualtierotti R., Boasi N., Pagliaro E., Massimo C., De Caro M., Giachi A., Vigone B., Bellocchi C., Carandina A., Fiorelli E., Melli V., Tobaldini E., Aliberti S., Spotti M., Terranova L., Misuraca S., D'Adda A., Fiore S. D., Di Pasquale M., Mantero M., Contarini M., Ori M., Morlacchi L., Rossetti V., Gramegna A., Pappalettera M., Cavallini M., Buscemi A., Vicenzi M., Rota I., Costantino G., Solbiati M., Furlan L., Mancarella M., Colombo G., Fanin A., Passarella M., Monzani V., Rovellini A., Barbetta L., Billi F., Folli C., Accordino S., Maira D., Hu C. M., Motta I., Scar-Amellini N., Fracanzani A. L., Lombardi R., Cespiati A., Cesari M., Lucchi T., Proietti M., Calcaterra L., Mandelli C., Coppola C., Cerizza A., Maria Pesenti A., Grasselli G., Galazzi A., Tet-Tamanti M., Monti I., Galbussera A. A., Crisafulli E., Girelli D., Maroccia A., Gabbiani D., Busti F., Vianello A., Biondan M., Sartori F., Faverio P., Pesci A., Zucchetti S., Bonfanti P., Rossi M., Beretta I., Spolti A., Harari S., Elia D., Cassandro R., Caminati A., Cipollone F., Guagnano M. T., D'Ardes D., Rossi I., Vezzani F., Spanevello A., Cherubino F., Visca D., Contoli M., Papi A., Morandi L., Battistini N., Luigi Moreo G., Iannuzzi P., Fumagalli D., Leone S., Oud J. A., Baysan M., Wigb J., van Heurn L. J., ter Haar S. B., Toppenberg A. G. L., Heerdink L., van IJlzinga Veenstra A. A., Eikenboom A. M., Wubbolts J., Uzorka J., Lijferink W., Meier R., de Jonge I. -B., Arbous S. M., de Boer M. G. J., van der Bom J. G., Dekkers O. M., Hassan, S, Ramspek, C, Ferrari, B, van Diepen, M, Rossio, R, Knevel, R, la Mura, V, Artoni, A, Martinelli, I, Bandera, A, Nobili, A, Gori, A, Blasi, F, Canetta, C, Montano, N, Rosendaal, F, Peyvandi, F, Bosari, S, Scudeller, L, Fusetti, G, Rusconi, L, Dell'Orto, S, Prati, D, Valenti, L, Giovannelli, S, Manunta, M, Lamorte, G, Ferarri, F, Muscatello, A, Mangioni, D, Alagna, L, Bozzi, G, Lombardi, A, Ungaro, R, Ancona, G, Zuglian, G, Bolis, M, Iannotti, N, Ludovisi, S, Comelli, A, Renisi, G, Biscarini, S, Castelli, V, Palomba, E, Fava, M, Fortina, V, Peri, C, Saltini, P, Viero, G, Itri, T, Ferroni, V, Pastore, V, Massafra, R, Liparoti, A, Muheberimana, T, Giommi, A, Bianco, R, De Azevedo, R, Chitani, G, Gualtierotti, R, Boasi, N, Pagliaro, E, Massimo, C, De Caro, M, Giachi, A, Vigone, B, Bellocchi, C, Carandina, A, Fiorelli, E, Melli, V, Tobaldini, E, Aliberti, S, Spotti, M, Terranova, L, Misuraca, S, D'Adda, A, Fiore, S, Di Pasquale, M, Mantero, M, Contarini, M, Ori, M, Morlacchi, L, Rossetti, V, Gramegna, A, Pappalettera, M, Cavallini, M, Buscemi, A, Vicenzi, M, Rota, I, Costantino, G, Solbiati, M, Furlan, L, Mancarella, M, Colombo, G, Fanin, A, Passarella, M, Monzani, V, Rovellini, A, Barbetta, L, Billi, F, Folli, C, Accordino, S, Maira, D, Hu, C, Motta, I, Scar-Amellini, N, Fracanzani, A, Lombardi, R, Cespiati, A, Cesari, M, Lucchi, T, Proietti, M, Calcaterra, L, Mandelli, C, Coppola, C, Cerizza, A, Maria Pesenti, A, Grasselli, G, Galazzi, A, Tet-Tamanti, M, Monti, I, Galbussera, A, Crisafulli, E, Girelli, D, Maroccia, A, Gabbiani, D, Busti, F, Vianello, A, Biondan, M, Sartori, F, Faverio, P, Pesci, A, Zucchetti, S, Bonfanti, P, Rossi, M, Beretta, I, Spolti, A, Harari, S, Elia, D, Cassandro, R, Caminati, A, Cipollone, F, Guagnano, M, D'Ardes, D, Rossi, I, Vezzani, F, Spanevello, A, Cherubino, F, Visca, D, Contoli, M, Papi, A, Morandi, L, Battistini, N, Luigi Moreo, G, Iannuzzi, P, Fumagalli, D, Leone, S, Oud, J, Baysan, M, Wigb, J, van Heurn, L, ter Haar, S, Toppenberg, A, Heerdink, L, van IJlzinga Veenstra, A, Eikenboom, A, Wubbolts, J, Uzorka, J, Lijferink, W, Meier, R, de Jonge, I, Arbous, S, de Boer, M, van der Bom, J, Dekkers, O, Hassan S., Ramspek C. L., Ferrari B., van Diepen M., Rossio R., Knevel R., la Mura V., Artoni A., Martinelli I., Bandera A., Nobili A., Gori A., Blasi F., Canetta C., Montano N., Rosendaal F. R., Peyvandi F., Bosari S., Scudeller L., Fusetti G., Rusconi L., Dell'Orto S., Prati D., Valenti L., Giovannelli S., Manunta M., Lamorte G., Ferarri F., Muscatello A., Mangioni D., Alagna L., Bozzi G., Lombardi A., Ungaro R., Ancona G., Zuglian G., Bolis M., Iannotti N., Ludovisi S., Comelli A., Renisi G., Biscarini S., Castelli V., Palomba E., Fava M., Fortina V., Peri C. A., Saltini P., Viero G., Itri T., Ferroni V., Pastore V., Massafra R., Liparoti A., Muheberimana T., Giommi A., Bianco R., De Azevedo R. M., Chitani G. E., Gualtierotti R., Boasi N., Pagliaro E., Massimo C., De Caro M., Giachi A., Vigone B., Bellocchi C., Carandina A., Fiorelli E., Melli V., Tobaldini E., Aliberti S., Spotti M., Terranova L., Misuraca S., D'Adda A., Fiore S. D., Di Pasquale M., Mantero M., Contarini M., Ori M., Morlacchi L., Rossetti V., Gramegna A., Pappalettera M., Cavallini M., Buscemi A., Vicenzi M., Rota I., Costantino G., Solbiati M., Furlan L., Mancarella M., Colombo G., Fanin A., Passarella M., Monzani V., Rovellini A., Barbetta L., Billi F., Folli C., Accordino S., Maira D., Hu C. M., Motta I., Scar-Amellini N., Fracanzani A. L., Lombardi R., Cespiati A., Cesari M., Lucchi T., Proietti M., Calcaterra L., Mandelli C., Coppola C., Cerizza A., Maria Pesenti A., Grasselli G., Galazzi A., Tet-Tamanti M., Monti I., Galbussera A. A., Crisafulli E., Girelli D., Maroccia A., Gabbiani D., Busti F., Vianello A., Biondan M., Sartori F., Faverio P., Pesci A., Zucchetti S., Bonfanti P., Rossi M., Beretta I., Spolti A., Harari S., Elia D., Cassandro R., Caminati A., Cipollone F., Guagnano M. T., D'Ardes D., Rossi I., Vezzani F., Spanevello A., Cherubino F., Visca D., Contoli M., Papi A., Morandi L., Battistini N., Luigi Moreo G., Iannuzzi P., Fumagalli D., Leone S., Oud J. A., Baysan M., Wigb J., van Heurn L. J., ter Haar S. B., Toppenberg A. G. L., Heerdink L., van IJlzinga Veenstra A. A., Eikenboom A. M., Wubbolts J., Uzorka J., Lijferink W., Meier R., de Jonge I. -B., Arbous S. M., de Boer M. G. J., van der Bom J. G., and Dekkers O. M.
- Abstract
Background: The coronavirus disease 2019 (COVID-19) presents an urgent threat to global health. Prediction models that accurately estimate mortality risk in hospitalized patients could assist medical staff in treatment and allocating limited resources. Aims: To externally validate two promising previously published risk scores that predict in-hospital mortality among hospitalized COVID-19 patients. Methods: Two prospective cohorts were available; a cohort of 1028 patients admitted to one of nine hospitals in Lombardy, Italy (the Lombardy cohort) and a cohort of 432 patients admitted to a hospital in Leiden, the Netherlands (the Leiden cohort). The endpoint was in-hospital mortality. All patients were adult and tested COVID-19 PCR-positive. Model discrimination and calibration were assessed. Results: The C-statistic of the 4C mortality score was good in the Lombardy cohort (0.85, 95CI: 0.82−0.89) and in the Leiden cohort (0.87, 95CI: 0.80−0.94). Model calibration was acceptable in the Lombardy cohort but poor in the Leiden cohort due to the model systematically overpredicting the mortality risk for all patients. The C-statistic of the CURB-65 score was good in the Lombardy cohort (0.80, 95CI: 0.75−0.85) and in the Leiden cohort (0.82, 95CI: 0.76−0.88). The mortality rate in the CURB-65 development cohort was much lower than the mortality rate in the Lombardy cohort. A similar but less pronounced trend was found for patients in the Leiden cohort. Conclusion: Although performances did not differ greatly, the 4C mortality score showed the best performance. However, because of quickly changing circumstances, model recalibration may be necessary before using the 4C mortality score.
- Published
- 2022
3. Depressive dimension, clinical outcome, and duration of hospitalization in acute schizophrenia
- Author
-
Mauri, Massimo C., Paletta, Silvia, Moliterno, Donatella, Colasanti, Alessandro, and Altamura, Carlo A.
- Published
- 2010
- Full Text
- View/download PDF
4. Depression in schizophrenia: Comparison of first- and second-generation antipsychotic drugs
- Author
-
Mauri, Massimo C., Moliterno, Donatella, Rossattini, Matteo, and Colasanti, Alessandro
- Published
- 2008
- Full Text
- View/download PDF
5. Normal and cancer-prone human cells respond differently to extremely low frequency magnetic fields
- Author
-
Mangiacasale, Rosamaria, Tritarelli, Alessandra, Sciamanna, Ilaria, Cannone, Maria, Lavia, Patrizia, Barberis, Massimo C., Lorenzini, Rodolfo, and Cundari, Enrico
- Published
- 2001
- Full Text
- View/download PDF
6. Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease.
- Author
-
Zorzi, Francesca, Ghosh, Subrata, Chiaramonte, Carlo, Lolli, Elisabetta, Ventura, Martina, Onali, Sara, De Cristofaro, Elena, Fantini, Massimo C., Biancone, Livia, Monteleone, Giovanni, and Calabrese, Emma
- Abstract
Mucosal healing, determined by ileocolonoscopy, is a goal for treatment of Crohn's disease (CD), but this is an invasive assessment procedure. We investigated whether response to tumor necrosis factor (TNF) antagonists, determined by small-intestine contrast ultrasonography, associates with long-term outcomes. We performed observational study of 80 patients with CD treated with anti-TNF agents for at least 1 year who underwent serial small intestine contrast ultrasonography (SICUS) at the University of Rome, in Italy. SICUS was used to evaluate disease site (based on bowel wall thickness), extent of lesions, and presence of complications. Inclusion criteria required pre-therapy SICUS with follow-up SICUS after 18 months. At second SICUS, patients were assigned to categories of complete or partial responder or non-responder. CD-related outcomes (corticosteroid need, hospitalization, and surgery) were assessed at 1 year from the second SICUS, using multivariate models, and were analyzed after long term follow up (5 years) using Kaplan-Meier survival analysis. Based on SICUS, after a median of 18 months, 36 patients (51%) were complete responders, 30 were partial responders (34%), and 13 were non-responders (15%). At 1 year from the second SICUS, no patients with a complete response, based on ultrasonography, underwent surgery, in comparison to partial responders (P =.0003) or non-responders (P =.001). Complete responders used smaller amounts of corticosteroids than partial responders (P =.0001) or non-responders (P <.0001). Complete responders required fewer hospitalizations than non-responders (P =.001). Kaplan-Meier survival analysis of long-term follow up data demonstrated a lower cumulative probability of need for surgery, hospitalization, and need for steroids among SICUS-categorized complete responders (P <.0001, P =.003 and P =.0001 respectively) than SICUS-categorized non-responders. In patients with CD, response to anti-TNF agents, determined by SICUS, is associated with better long-term outcomes than partial or no response. Ultrasonographic assessment therefore provides a relatively non-invasive method for monitoring response to treatment in patients with CD. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Cryo-electron microscopy of extracellular vesicles associated with the marine toxic dinoflagellate Alexandrium minutum.
- Author
-
Pernice, Massimo C., Closa, Daniel, and Garcés, Esther
- Subjects
- *
EXTRACELLULAR vesicles , *ALEXANDRIUM , *GYMNODINIUM , *TRANSMISSION electron microscopy , *AXENIC cultures , *MICROSCOPY - Abstract
• The presence of extracellular vesicles was proven with cryo-electron microscopy in a near-axenic culture of the toxic dinoflagellate Alexandrium minutum. • Five different morphotypes were retrieved from the near-axenic culture (rounded, double, rounded electron-dense, lumen electron-dense and irregular), this plurality of shapes suggests a plurality of functions. • The average size of the extracellular vesicles retrieved from the near-axenic culture was of 0.36 µm, which is larger than the average of 0.1 µm of vesicles clearly belonging to prokaryotes. Extracellular Vesicles (EVs) are likely an important strategy of transport and communication in marine microbial community. Their isolation and characterization from axenic culture of microbial eukaryotes represents a technological challenge not fully solved. Here, for the first time, we isolated EVs from a near-axenic culture of the toxic dinoflagellate Alexandrium minutum. Pictures of the isolated vesicles were done with Cryo TEM (Cryogenic Transmission Electron Microscopy). Based on their morphotype the EVs were clustered in five major groups (rounded, rounded electron-dense, lumen electron-dense, double and irregular) and each EV was measured resulting in an average size of 0.36 µm of diameter. Taking in account that in prokaryotes it has been demonstrated that EVs play an important role in the mechanism of toxicity, this descriptive work aims to be the first step to study the possible role of EVs in the toxicity of dinoflagellates. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease.
- Author
-
Monteleone, Giovanni, Fantini, Massimo C, Onali, Sara, Zorzi, Francesca, Sancesario, Giulia, Bernardini, Sergio, Calabrese, Emma, Viti, Francesca, Monteleone, Ivan, Biancone, Livia, and Pallone, Francesco
- Subjects
- *
CROHN'S disease , *CLINICAL trials , *T cells , *CYTOKINES , *GROWTH factors - Abstract
In the gut of patients with Crohn's disease (CD), high Smad7 blocks the immune-suppressive activity of transforming growth factor (TGF)-β1, thereby contributing to amplify inflammatory signals. In vivo in mice, knockdown of Smad7 with a Smad7 antisense oligonucleotide (GED0301) attenuates experimental colitis. Here, we provide results of a phase 1 clinical, open-label, dose-escalation study of GED0301 in patients with active, steroid-dependent/resistant CD, aimed at assessing the safety and tolerability of the drug. Patients were allocated to three treatment groups receiving oral GED0301 once daily for 7 days at doses of 40, 80, or 160 mg. A total of 15 patients were enrolled. No serious adverse event was registered. GED0301 was well tolerated and no patient dropped out during the study. Twenty-five adverse events were documented in 11 patients, the majority of whom were judged to be of mild intensity and unrelated to treatment. GED0301 treatment reduced the percentage of inflammatory cytokine-expressing CCR9-positive T cells in the blood. The study shows for the first time that GED0301 is safe and well tolerated in patients with active CD. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
9. Regulation of Gut Inflammation and Th17 Cell Response by Interleukin-21.
- Author
-
Fina, Daniele, Sarra, Massimiliano, Fantini, Massimo C., Rizzo, Angelamaria, Caruso, Roberta, Caprioli, Flavio, Stolfi, Carmine, Cardolini, Iris, Dottori, Marta, Boirivant, Monica, Pallone, Francesco, MacDonald, Thomas T., and Monteleone, Giovanni
- Subjects
INFLAMMATION ,LYMPHOCYTES ,T cells ,LEUCOCYTES - Abstract
Background & Aims: Interleukin (IL)-21, a T-cell-derived cytokine, is overproduced in inflammatory bowel diseases (IBD), but its role in the pathogenesis of gut inflammation remains unknown. We here examined whether IL-21 is necessary for the initiation and progress of experimental colitis and whether it regulates specific pathways of inflammation. Methods: Both dextran sulfate sodium colitis and trinitrobenzene sulfonic acid-relapsing colitis were induced in wild-type and IL-21-deficient mice. CD4
+ CD25− T cells from wild-type and IL-21-deficient mice were differentiated in T helper cell (Th)17-polarizing conditions, with or without IL-21 or an antagonistic IL-21R/Fc. We also examined whether blockade of IL-21 by anti-IL-21 antibody reduced IL-17 in cultures of IBD lamina propria CD3+ T lymphocytes. Cytokines were evaluated by real-time polymerase chain reaction and/or enzyme-linked immunosorbent assay. Results: High IL-21 was seen in wild-type mice with dextran sulfate sodium- and trinitrobenzene sulfonic acid-relapsing colitis. IL-21-deficient mice were largely protected against both colitides and were unable to up-regulate Th17-associated molecules during gut inflammation, thus suggesting a role for IL-21 in controlling Th17 cell responses. Indeed, naïve T cells from IL-21-deficient mice failed to differentiate into Th17 cells. Treatment of developing Th17 cells from wild-type mice with IL-21R/Fc reduced IL-17 production. Moreover, in the presence of transforming growth factor-β1, exogenous IL-21 substituted for IL-6 in driving IL-17 induction. Neutralization of IL-21 reduced IL-17 secretion by IBD lamina propria lymphocytes. Conclusions: These results indicate that IL-21 is a critical regulator of inflammation and Th17 cell responses in the gut. [Copyright &y& Elsevier]- Published
- 2008
- Full Text
- View/download PDF
10. Hallucinatory disorder, an original clinical picture? Clinical and imaging data
- Author
-
Mauri, Massimo C., Gaietta, Marco, Dragogna, Filippo, Valli, Isabel, Cerveri, Giancarlo, and Marotta, Giorgio
- Subjects
- *
HALLUCINATIONS , *SUBCONSCIOUSNESS , *PEOPLE with schizophrenia , *SCHIZOPHRENIA - Abstract
Abstract: Objective: The aim of this study was to verify the existence of areas of clinical and neurofunctional homogeneity in a group of patients with auditory verbal hallucinations (AVHs) as an isolated symptom, attributable to what we have called “Hallucinatory Disorder” (HD) in an attempt to propose a clinical picture that is distinct from Schizophrenia. Method: Nine patients clinically characterised by chronic AVHs were compared with nine schizophrenic patients using the Structured Clinical Interview for DSM-III-R, BPRS, PANSS, SAPS, SANS, HRS-A, HRS-D, CDSS, MMSE, CGI and PSYRATS. Both groups of patients and nine healthy subjects underwent EEG and SPECT examinations. Results: Considering the psychopathological dimensions of Schizophrenia, in the HD patients clinical evaluations revealed a mono-dimensional clinical profile, whereas all these dimensions contributed to the clinical picture of the schizophrenic patients. The SPECT data showed that the schizophrenic patients had a reduced rCBF in some areas of the right frontal lobe, while the HD patients did not show any area of hypoperfusion. The SPECT hyperperfusion data showed an activation pattern in the HD patients that was characterised by the involvement of various cortical and subcortical cerebral areas, similar to those found in studies of inner speech and auditory verbal imagery. Conclusions: The two groups of patients present significant differences that seem capable of supporting the proposed hypothesis that HD may be an independent nosographical entity. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
11. TGF-beta as a T cell regulator in colitis and colon cancer
- Author
-
Becker, Christoph, Fantini, Massimo C., and Neurath, Markus F.
- Subjects
- *
T cells , *CYTOKINES , *IMMUNOSUPPRESSION , *AUTOIMMUNE diseases , *PATHOLOGY , *COLON cancer - Abstract
Abstract: TGF-β is a pleiotropic cytokine with powerful immunosuppressive functions. Mice deficient for TGF-β1 show a dramatic phenotype with severe multiorgan inflammation and die shortly after birth. Recent investigations have highlighted the role of TGF-β in suppression of T cell mediated autoimmune inflammation and anti-tumor immunity. In addition to its direct anti-inflammatory effects on T cells, TGF-β has been implicated as central regulator of regulatory T cells. TGF-β not only mediates the suppression of effector T cells by Tregs, recent evidence also reveals a role for TGF-β along with TCR stimulation in the peripheral induction of regulatory T cells from naïve CD4+CD25− cells. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
12. Patterns of clinical use of antipsychotics in hospitalized psychiatric patients
- Author
-
Mauri, Massimo C., Regispani, Francesca, Beraldo, Scilla, Volonteri, Lucia S., Ferrari, Veronica M., Fiorentini, Alessio, and Invernizzi, Giordano
- Subjects
- *
ANTIPSYCHOTIC agents , *PSYCHIATRIC drugs , *CLONAZEPAM , *CLOPENTHIXOL - Abstract
Abstract: The ways of using antipsychotic drugs have greatly changed over the last 10 years. The aim of this study was to evaluate such changes in psychiatric patients admitted to the Psychiatric Department of Milan''s Ospedale Maggiore in 1989 (n =350), 1999 (n =718) and 2002 (n =628). The medical records of the hospitalized patients were evaluated by analyzing the anamnestic and clinical data with particular reference to age, gender, diagnosis and medication use. In 2002, atypical antipsychotics were more frequently prescribed as monotherapy upon discharge than typical antipsychotics (32.64% vs. 30.10%). Combinations of two or more antipsychotic drugs were prescribed upon discharge for 20.63% of the patients in 1989, 31.24% in 1999 and 23.09% in 2002. The combinations of one typical and one atypical drug increased from 4.04% in 1999 to 13.06% in 2002. The mean (±S.D.) daily antipsychotic drug dose (expressed in chlorpromazine equivalents) was significantly higher in 2002 than in 1999 and 1989. The results of this study confirm the trend to use combinations of one typical and one atypical antipsychotic, and higher doses. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
13. Nutritional management of anorexic patients with and without fluoxetine: 1-year follow-up
- Author
-
Ruggiero, Giovanni M., Mauri, Massimo C., Omboni, Anna C., Volonteri, Lucia S., Dipasquale, Savina, Malvini, Lara, Redaelli, Gabriella, Pasqualinotto, Lucia, and Cavagnini, Francesco
- Subjects
- *
APPETITE loss , *FLUOXETINE - Abstract
This study evaluated the efficacy of nutritional management with and without fluoxetine (FLX) in anorexia nervosa diagnosed according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria. Twenty-one patients, with a mean body mass index (BMI) of 15.21±2.33 kg/m2, were treated with nutritional management and FLX at a mean dosage of 30.00±9.35 mg (pharmacological group); seventy-four patients, with a mean BMI of 14.24±2.16 kg/m2, were treated only with nutritional management (nutritional group). Clinical evaluation was carried out under single-blind conditions at basal time and after 3, 6, and 12 months by a structured clinical interview, the Eating Disorder Interview based on Longitudinal Interval Follow-Up Evaluation (EDI-LIFE) and using a self-reported questionnaire, the Eating Disorder Inventory (EDI). BMI significantly increased in both the two treatment groups. In addition, the increase shown by the pharmacological group appeared near the beginning of treatment (i.e., at T1) and it was significantly higher than the increase shown by the nutritional group. Physical exercise showed a significant decrease in the pharmacological treatment group. On the other hand, fear of fatness and the scores of the subscales of the EDI significantly decreased in the nutritional treatment group. In terms of weight, the pharmacological group presented the higher amount of therapeutic success. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
14. Clinical outcome and tolerability of sertraline in major depression: A study with plasma levels
- Author
-
Mauri, Massimo C., Laini, Valerio, Cerveri, Giancarlo, Scalvini, Marta E., Volonteri, Lucia S., Regispani, Francesca, Malvini, Lara, Manfré, Sergio, Boscati, Luigi, and Panza, Gabriele
- Subjects
- *
SERTRALINE , *ANTIDEPRESSANTS , *MENTAL illness - Abstract
Sertraline (SRT) has been shown to be an effective antidepressant in extensive clinical trial programs but data on plasma concentrations regarding clinical outcome and tolerability are lacking. Twenty-one out-patients of both sexes, with mean age of 50.23 years (S.D.=17.37), affected by major depressive disorder, recurrent (Diagnostic and Statistical Manual of Mental Disorder—IV, DSM-IV), were treated with 25–150 mg of SRT once a day (mean=66.26 mg, S.D.=30.50) for 30 days. Clinical evaluation was assessed at baseline (T0), after 15 days (T15), and then after 30 days (T30). Plasma samples for SRT level determination were collected at T30. Brief Psychiatric Rating Scale (BPRS), Hamilton Rating Scale for Depression (HRS-D), and Hamilton Rating Scale for Anxiety (HRS-A) showed a significant improvement during the study (P<.01 vs. T0). The most commonly reported side effects were nausea (19%), cephalalgia (9.5%), dry mouth (9.5%), decreased libido (9.5%), tremor (4.7%), and tachycardia (4.7%). SRT plasma levels ranged from 2.82 to 112.20 ng/ml (mean=40.42 ng/ml, S.D.=26.93). No correlation between SRT plasma levels and clinical improvement or side effects were observed. Drug plasma level determination does not seem be strictly necessary from a clinical point of view but further research seems advisable in patients at risk like elderly and during long-term studies. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
15. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
- Author
-
Tang, Yilang, Reissig, Sonja, Glasmacher, Elke, Regen, Tommy, Wanke, Florian, Nikolaev, Alexei, Gerlach, Katharina, Popp, Vanessa, Karram, Khalad, Fantini, Massimo C., Schattenberg, Jörn M., Galle, Peter R., Neurath, Markus F., Weigmann, Benno, Kurschus, Florian C., Hövelmeyer, Nadine, and Waisman, Ari
- Abstract
Background & Aims The CYLD lysine 63 deubiquitinase gene (CYLD) encodes tumor suppressor protein that is mutated in familial cylindromatosus, and variants have been associated with Crohn disease (CD). Splice forms of CYLD that lack exons 7 and 8 regulate transcription factors and functions of immune cells. We examined the expression of splice forms of CYLD in colon tissues from patients with CD and their effects in mice. Methods We performed immunohistochemical analyses of colon tissues from patients with untreated CD and patients without inflammatory bowel diseases (controls). We obtained mice that expressed splice forms of CYLD (sCYLD mice) without or with SMAD7 (sCYLD/SMAD7 mice) from transgenes and CYLD-knockout mice (with or without transgenic expression of SMAD7) and performed endoscopic analyses. Colitis was induced in Rag1
−/− mice by transfer of CD4+ CD62L+ T cells from C57/Bl6 or transgenic mice. T cells were isolated from mice and analyzed by flow cytometry and quantitative real-time polymerase chain reaction and intestinal tissues were analyzed by histology and immunohistochemistry. CYLD forms were expressed in mouse embryonic fibroblasts, primary T cells, and HEK293T cells, which were analyzed by immunoblot, mobility shift, and immunoprecipitation assays. Results The colonic lamina propria from patients with CD was infiltrated by T cells and had higher levels of sCYLD (but not full-length CYLD) and SMAD7 than tissues from controls. Incubation of mouse embryonic fibroblasts and T cells with transforming growth factor β increased their production of sCYLD and decreased full-length CYLD. Transgenic expression of sCYLD and SMAD7 in T cells prevented the differentiation of regulatory T cells and T-helper type 17 cells and increased the differentiation of T-helper type 1 cells. The same effects were observed in colon tissues from sCYLD/SMAD7 mice but not in those from CYLD-knockout SMAD7 mice. The sCYLD mice had significant increases in the numbers of T-helper type 1 cells and CD44high CD62Llow memory–effector CD4+ T cells in the spleen and mesenteric lymph nodes compared with wild-type mice; sCYLD/SMAD7 mice had even larger increases. The sCYLD/SMAD7 mice spontaneously developed severe colitis, with infiltration of the colon by dendritic cells, neutrophils, macrophages, and CD4+ T cells and increased levels of Ifng , Il6 , Il12a , Il23a , and Tnf mRNAs. Co-transfer of regulatory T cells from wild-type, but not from sCYLD/SMAD7, mice prevented the induction of colitis in Rag1−/− mice by CD4+ T cells. We found increased levels of poly-ubiquitinated SMAD7 in sCYLD CD4+ T cells. CYLD formed a nuclear complex with SMAD3, whereas sCYLD recruited SMAD7 to the nucleus, which inhibited the expression of genes regulated by SMAD3 and SMAD4. We found that sCYLD mediated lysine 63–linked ubiquitination of SMAD7. The sCYLD–SMAD7 complex inhibited transforming growth factor β signaling in CD4+ T cells. Conclusions Levels of the spliced form of CYLD are increased in colon tissues from patients with CD. sCYLD mediates ubiquitination and nuclear translocation of SMAD7 and thereby decreases transforming growth factor β signaling in T cells. This prevents immune regulatory mechanisms and leads to colitis in mice. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
16. Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients
- Author
-
Mauri, Massimo C., Volonteri, Lucia S., Fiorentini, Alessio, Invernizzi, Giordano, Nerini, Teresa, Baldi, Marialuisa, and Bareggi, Silvio R.
- Published
- 2004
- Full Text
- View/download PDF
17. Su2060 - Treat to Target in Crohn’s Disease: Ultrasonographic Response is Associated with Better Outcomes.
- Author
-
Zorzi, Francesca, Lolli, Elisabetta, Onali, Sara, Petruzziello, Carmelina, Fantini, Massimo C., Biancone, Livia, Monteleone, Giovanni, and Calabrese, Emma
- Published
- 2017
- Full Text
- View/download PDF
18. The impact of translational research on gastroenterology.
- Author
-
Di Sabatino, Antonio, Moschetta, Antonio, Conte, Dario, Tiribelli, Claudio, Caprioli, Flavio Andrea, Fabris, Luca, Fantini, Massimo C., Frulloni, Luca, Monteleone, Giovanni, Romano, Marco, Sarnelli, Giovanni, and Baroni, Gianluca Svegliati
- Published
- 2014
- Full Text
- View/download PDF
19. Sa1425 CCL20 Is Negatively Regulated by TGF-B1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a SMAD7 Antisense Oligonucleotide.
- Author
-
Marafini, Irene, Monteleone, Ivan, Di Fusco, Davide, De Simone, Veronica, Dinallo, Vincenzo, Laudisi, Federica, Fantini, Massimo C., Di Sabatino, Antonio, Pallone, Francesco, and Monteleone, Giovanni
- Published
- 2016
- Full Text
- View/download PDF
20. Tu1998 Effectiveness of a Training Program on Motivational Interviewing (MI) Skills Applied to Inflammatory Bowel Disease (IBD) Management.
- Author
-
Daperno, Marco, Mocciaro, Filippo, Caprioli, Flavio, Fantini, Massimo C., Leone, Salvatore, Comberlato, Michele, and Quercia, Valerio
- Published
- 2016
- Full Text
- View/download PDF
21. High Expression of ADAM19, a Sheddase for TNF-Alpha, in the Mucosa of Patients With Inflammatory Bowel Disease (IBD).
- Author
-
De Nitto, Daniela, Franzè, Eleonora, Caprioli, Flavio, Carli, Sara, Sileri, Pierpaolo, Sica, Giuseppe S., Biancone, Livia, Stolfi, Carmine, Rizzo, Angelamaria, Fantini, Massimo C., Pallone, Francesco, and Monteleone, Giovanni
- Published
- 2011
- Full Text
- View/download PDF
22. M1956 High IFN-Gamma Expression is Required for Tumor Protection in a Model of Colitis-Associated Colorectal Cancer.
- Author
-
Fantini, Massimo C., Rizzo, Angelamaria, Fina, Daniele, Caruso, Roberta, Sarra, Massimiliano, Stolfi, Carmine, Becker, Christoph, MacDonald, Thomas T., Pallone, Francesco, Neurath, Markus F., and Monteleone, Giovanni
- Published
- 2010
- Full Text
- View/download PDF
23. 365 The Lymphatic System Controls Intestinal Inflammation and Inflammation-Associated Colon Cancer Through the Chemokine Decoy Receptor D6.
- Author
-
Vetrano, Stefania, Borroni, Elena M., Bonecchi, Raffaella, Correale, Carmen, Sarukhan, Adelaida, Arena, Vincenzo, Fantini, Massimo C., Roncalli, Massimo, Malesci, Alberto, Vecchi, Annunciata, Mantovani, Alberto, Locati, Massimo, and Danese, Silvio
- Published
- 2009
- Full Text
- View/download PDF
24. 241 Interleukin (IL)-25 Inhibits IL-12 Production and TH1 Cell-Driven Inflammation in the Gut.
- Author
-
Caruso, Roberta, Sarra, Massimiliano, Stolfi, Carmine, Rizzo, Angelamaria, Fantini, Massimo C., Pallone, Francesco, MacDonald, Thomas T., and Monteleone, Giovanni
- Published
- 2009
- Full Text
- View/download PDF
25. 52 Smad7 Expression in T Cells Protects from Colitis-Associated Colorectal Cancer.
- Author
-
Fantini, Massimo C., Rizzo, Angelamaria, Fina, Daniele, Caruso, Roberta, Sarra, Massimiliano, Stolfi, Carmine, Becker, Christoph, MacDonald, Thomas T., Pallone, Francesco, Neurath, Markus F., and Monteleone, Giovanni
- Published
- 2009
- Full Text
- View/download PDF
26. Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression.
- Author
-
Fantini, Massimo C., Rizzo, Angelamaria, Fina, Daniele, Caruso, Roberta, Sarra, Massimiliano, Stolfi, Carmine, Becker, Christoph, MacDonald, Thomas T., Pallone, Francesco, Neurath, Markus F., and Monteleone, Giovanni
- Subjects
T cells ,CELL physiology ,GENE expression ,HOMEOSTASIS ,TRANSFORMING growth factors-beta ,CELL proliferation ,TRANSGENIC mice ,CELLULAR immunity ,INFLAMMATORY bowel diseases - Abstract
Background & Aims: Foxp3-expressing regulatory T cells (Tregs) play a key role in the maintenance of the gut immune homeostasis, and an intact transforming growth factor (TGF)-β signaling is required for their function. In inflammatory bowel disease (IBD), the TGF-β signaling is impaired because of high expression of the inhibitory molecule Smad7. Although no intrinsic defects in Tregs function have been shown in IBD, it is still unknown whether colitogenic T cells are susceptible to Treg-mediated suppression. In this study, we have investigated whether IBD mucosal CD4+ T cells are resistant to Tregs and whether Smad7 is involved in this process. Methods: IBD lamina propria mononuclear cells (LPMC) were cultured with or without Tregs, and proliferation was assessed by flow cytometry. Proliferation of IBD LPMC was also evaluated after Smad7 antisense oligonuclotide treatment. Treg-mediated suppression of T-cell proliferation and proinflammatory cytokine expression was investigated in murine Smad7 transgenic cells. In vivo, the Smad7-dependent resistance of colitogenic naïve T cells to Tregs was studied in the adoptive transfer model of colitis. Results: IBD LPMC were resistant to Treg-mediated suppression, and this phenomenon was reverted by Smad7 antisense treatment. Consistently, CD4+ T cells isolated from Smad7 transgenic mice showed high proliferation, produced considerable amount of inflammatory cytokines following activation, and induced a severe colitis when transferred in immunodeficient RAG1 knockout mice even in the presence of wild-type Tregs. Conclusions: Smad7 makes CD4+ T cells resistant to Tregs-mediated suppression thus fine-tuning their proinflammatory potential. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
27. W1109 In Vitro and In Vivo Inhibition of Colorectal Cancer (CRC) Cell Growth By 2-14, a Novel Derivative of 5-Aminosalycilic Acid.
- Author
-
Stolfi, Carmine, Fina, Daniele, Caruso, Roberta, Caprioli, Flavio, Sarra, Massimiliano, Fantini, Massimo C., Rizzo, Angelamaria, Pallone, Francesco, and Monteleone, Giovanni
- Published
- 2008
- Full Text
- View/download PDF
28. S1719 Regulation of Gut Inflammation and TH17 Cell Response By Interleukin-21.
- Author
-
Fina, Daniele, Sarra, Massimiliano, Fantini, Massimo C., Rizzo, Angelamaria, Caruso, Roberta, Caprioli, Flavio, Stolfi, Carmine, Cardolini, Iris, Boirivant, Monica, Pallone, Francesco, MacDonald, Thomas T., and Monteleone, Giovanni
- Published
- 2008
- Full Text
- View/download PDF
29. 972 Unique Role of Junctional Adhesion Molecule-a in Maintaining Mucosal Homeostasis in Inflammatory Bowel Disease.
- Author
-
Vetrano, Stefania, Rescigno, Maria, Cera, Maria Rosaria, Doni, Andrea, Correale, Carmen, Fantini, Massimo C., Sturm, Andreas, Borroni, Elena, Repici, Alessandro, Rumi, Cristiano, Locati, Massimo, Malesci, Alberto, Dejana, Elisabetta, and Danese, Silvio
- Published
- 2008
- Full Text
- View/download PDF
30. 517 T Cell-Specific Smad7 Over-Expression Reduces Regulatory T Cell-Mediated Control of Colitis.
- Author
-
Fantini, Massimo C., Rizzo, Angelamaria, Fina, Daniele, Sarra, Massimiliano, Caruso, Roberta, Becker, Christoph, Pallone, Francesco, Macdonald, Thomas T., Neurath, Markus F., and Monteleone, Giovanni
- Published
- 2008
- Full Text
- View/download PDF
31. 401 The Atypical Chemokine Receptor D6 Controls Intestinal Inflammation and Inflammation-Associated Colon Cancer.
- Author
-
Vetrano, Stefania, Borroni, Elena, Bonecchi, Raffaella, Correale, Carmen, Arena, Vincenzo, Fantini, Massimo C., Malesci, Alberto, Vecchi, Annunciata, Mantovani, Alberto, Locati, Massimo, and Danese, Silvio
- Published
- 2008
- Full Text
- View/download PDF
32. Cystic lung diseases: radiological aspects.
- Author
-
Valente, T., Guarino, S., Lassandro, G., Picchi, S.G., Romano, F., Massimo, C., Rea, G., Lieto, R., Nicola, R., and Lassandro, F.
- Subjects
- *
LUNG diseases , *LUNGS , *RADIOLOGISTS , *PHYSICIANS , *BRONCHIECTASIS , *CYSTS (Pathology) - Abstract
Cystic lung diseases (CLDs) are a heterogeneous group of pathophysiological entities comprising gas-filled lesions with imperceptible walls, which can occur throughout lung parenchyma. CLDs can arise from different mechanisms and may often have an unpredictable progression. As CLDs are infrequent and may be associated to many different processes, they pose a diagnostic challenge to the radiologist and referring physician. CLDs require a comprehensive diagnostic approach. An essential tool in the evaluation of CLDs is high-resolution computed tomography (HRCT). The first step is in distinction from true cysts, from other cysts mimicking entities, as emphysema, honeycombing, pneumatocoele, cavitate nodules, or bronchiectasis. Thereafter the identification of number, distribution, wall size, and other systemic manifestations provides an accurate characterisation of CLD, often avoiding further evaluation with lung biopsy. Features of pulmonary lucencies, classification of CLDs based on pathophysiological mechanisms, and radiological criteria, the less common aetiologies, and a multidisciplinary approach in pulmonary cysts are reported. Finally, a systematic diagnostic algorithm to guide radiologists in the evaluation of CLDs is discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: The effects of l-thyroxine
- Author
-
Baldini, Marina, Colasanti, Alessandro, Orsatti, Alessandra, Airaghi, Lorena, Mauri, Massimo C., and Cappellini, Maria Domenica
- Subjects
- *
NEUROPSYCHOLOGY , *LIPID metabolism , *HYPOTHYROIDISM , *THYROXINE , *DISEASE incidence , *CLINICAL pathology , *NEUROPSYCHOLOGICAL tests , *MEDICAL care surveys , *THYROTROPIN - Abstract
Abstract: Thyroid hypofunction is a slowly progressing graded phenomenon [Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43(1):55–68]; subclinical forms (SCH) often represent a laboratory diagnosis in apparently asymptomatic patients. In the absence of adequate parameters for thyroid hormone action in tissues, the level of TSH increase corresponding to negative effects remains unsettled. We studied a wide range of physiological processes in a strictly selected population of 38 female patients (56.4±12.6 years) with minor forms of SCH (TSH 6.6±1.8 mIU/L), after exclusion of neurological, psychiatric and somatic disorders or confounding conditions. The investigations, performed at admission and after 6 months of l-thyroxine (LT4) treatment, included metabolic evaluation, health status perception and an extensive battery of neuropsychological tests and psychological rating scales. Lipid metabolism improved after LT4 (total cholesterol: 231.9±49.6 mg/dl pre- vs 221.0±40.0 mg/dl post-treatment; LDL cholesterol: 183.1±62.9 vs 162.7±53.7 mg/dl; apolipoprotein A1: 183.5±64.5 vs 160.9±50.3 mg/dl; p <0.05 for all comparisons), while glucose metabolism was unchanged. Health status perception was favourably influenced by the treatment (total SF-36 score 97.8±18.4 pre- vs 108.5±14.8 post-, p <0.0001); in a matched control group with euthyroid goiter, tested to examine the effects of medical care in the absence of treatment, no significant differences were found in the SF-36 scores at admission and after 6 months (109.3±15.1 vs 109±14.2, p =0.9). Attention performance improved after LT4; HRSD and HRSA scores did not significantly change, but negative correlations were found between FT3 levels and affective scores at admission, and between the post-treatment changes of affective scores and of FT3. In our study subtle disturbances of health status perception, attention and lipid metabolism associated to SCH of mildest degrees were reverted by LT4 replacement, reinforcing reports of unfavourable consequences of marginal thyroid disease. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
34. Perfectionism in depression, obsessive-compulsive disorder and eating disorders
- Author
-
Sassaroli, Sandra, Romero Lauro, Leonor J., Maria Ruggiero, Giovanni, Mauri, Massimo C., Vinai, Piergiuseppe, and Frost, Randy
- Subjects
- *
OBSESSIVE-compulsive disorder , *NEUROSES , *COMPULSIVE behavior , *COMPULSIVE hair pulling - Abstract
Abstract: High levels of perfectionism have been observed in major depression, anxiety disorders and eating disorders. Though few studies have compared levels of perfectionism across these disorders, there is reason to believe that different dimensions of perfectionism may be involved in eating disorders than in depression or anxiety [Bardone-Cone, A. M. et al. (2007). Perfectionism and eating disorders: Current status and future directions. Clinical Psychology Review, 27, 84–405]. The present study compared patients with major depression, obsessive-compulsive disorder, and eating disorders on dimensions of perfectionism. Concern over Mistakes was elevated in each of the patient groups while Pure Personal Standards was only elevated in the eating disorder sample. Doubts about Actions was elevated in both patients with obsessive-compulsive disorder and eating disorders, but not in depressed patients. Analyses of covariance indicated that Concern over Mistakes accounted for most of the variance in the relationship of perfectionism to these forms of psychopathology. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
35. Depression in schizophrenia: Clinical and pharmacological variables
- Author
-
Mauri, Massimo C., Bravin, Silvia, Mantero, Mario, and Invernizzi, Giordano
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.